Digital Twin Technology: The Next Frontier in Personalized Oncology

Abstract

Cancer remains one of the most complex diseases confronting modern medicine because of its remarkable biological heterogeneity, dynamic evolution, and highly individualized therapeutic responses. Despite substantial advances in molecular diagnostics, targeted therapies, immunotherapy, and precision medicine, considerable variability in clinical outcomes continues to challenge conventional treatment strategies. Recent developments in artificial intelligence (AI), computational biology, systems medicine, mathematical modeling, and multimodal biomedical data integration have introduced digital twin technology as one of the most promising innovations in personalized oncology. A digital twin is a continuously evolving virtual representation of an individual patient that integrates radiological imaging, digital pathology, genomic sequencing, transcriptomics, proteomics, metabolomics, laboratory biomarkers, physiological monitoring, treatment history, and longitudinal clinical data to simulate disease progression and therapeutic response. Unlike traditional predictive models that analyze isolated datasets, digital twins provide dynamic, patient-specific computational ecosystems capable of supporting diagnosis, prognostic prediction, treatment optimization, toxicity assessment, adaptive therapy, and survivorship planning. Advances in machine learning, deep learning, transformer architectures, graph neural networks, reinforcement learning, generative AI, and foundation models have significantly accelerated the development of oncology digital twins by enabling continuous integration of heterogeneous biomedical information. These intelligent systems have demonstrated growing potential across tumor detection, radiogenomics, computational pathology, immunotherapy prediction, adaptive radiation therapy, surgical planning, drug discovery, and clinical decision support. Nevertheless, challenges remain regarding data harmonization, interoperability, computational complexity, cybersecurity, explainability, ethical governance, regulatory validation, and widespread clinical implementation. This review provides a comprehensive overview of digital twin technology in oncology, emphasizing its computational foundations, current clinical applications, emerging innovations, and future role in transforming personalized cancer care.[1]